New combo therapy tested to control advanced breast cancer
NCT ID NCT02668666
Summary
This study tested a combination of two oral drugs, palbociclib and tamoxifen, as the first treatment for women with advanced hormone-positive breast cancer that had spread. The goal was to see how long the treatment could control the cancer's growth and how well patients tolerated it. The trial was for patients who had not received any prior drug treatment for their advanced disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michigan State University
Lansing, Michigan, 48910, United States
-
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
-
ProHealth Care
Waukesha, Wisconsin, 53188, United States
-
University of Illinois Cancer Center
Chicago, Illinois, 60612, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.